ctrl K

Price Alert

Sonoma Pharmaceuticals In... (SNOA)

NASDAQ: SNOA · Real-Time Price · USD

5.35

0.00 (0.00%)

At close: Aug 18, 2025, 3:59 PM

5.20

-2.80%

Pre-market: Aug 19, 2025, 06:35 AM EDT

Sonoma Pharmaceuticals Income Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	14.29M	12.73M	13.27M	12.63M	18.63M
Cost of Revenue	8.82M	7.99M	8.79M	8.63M	12.07M
Gross Profit	5.46M	4.75M	4.48M	3.99M	6.56M
Operating Income	-3.71M	-4.7M	-4.57M	-5.89M	-3.45M
Interest Income	n/a	n/a	16K	10K	16K
Pretax Income	-2.91M	-5.03M	-5.18M	-5.42M	-3.9M
Net Income	-3.46M	-4.83M	-5.15M	-5.09M	-3.95M
Selling & General & Admin	7.36M	7.58M	8.84M	9.76M	9.45M
Research & Development	1.81M	1.87M	207K	125K	555K
Other Expenses	n/a	n/a	n/a	n/a	n/a
Operating Expenses	9.18M	9.45M	9.05M	9.88M	10.01M
Interest Expense	n/a	n/a	16K	10K	12K
Selling & Marketing Expenses	n/a	156K	156K	86K	41K
Cost & Expenses	18M	17.44M	17.84M	18.52M	22.08M
Income Tax Expense	550K	-196K	-33K	-332K	713K
Shares Outstanding (Basic)	1.24M	909K	339.4K	265.3K	199.6K
Shares Outstanding (Diluted)	1.24M	909K	339.4K	265.3K	199.6K
EPS (Basic)	-2.79	-5.32	-15.18	-19.17	-23.65
EPS (Diluted)	-2.79	-5.32	-15.18	-19.17	-23.65
EBITDA	-3.57M	-4.53M	-4.45M	-5.7M	-3.22M
EBIT	-3.71M	-4.7M	-4.57M	-5.89M	-3.45M
Depreciation & Amortization	138K	176K	125K	186K	227K